Neuroinflammation in the living brain of Parkinson's disease (Q37677181)

21 August 2017

1 reference

title

Neuroinflammation in the living brain of Parkinson's disease (English)

1 reference

21 August 2017

0 references

1 reference

Yasuomi Ouchi

1

1 reference

21 August 2017

Shunsuke Yagi

series ordinal

2

1 reference

21 August 2017

Masamichi Yokokura

series ordinal

3

1 reference

21 August 2017

Masanobu Sakamoto

series ordinal

4

1 reference

21 August 2017

1 December 2009

1 reference

Parkinsonism and Related Disorders

21 August 2017

1 reference

21 August 2017

15 Suppl 3

1 reference

21 August 2017

S200-4

1 reference

Characterisation of microglia isolated from adult human and rat brain

21 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970814-4

7 January 2021

Tumor necrosis factor alpha response elements in the HLA-DRA promoter: identification of a tumor necrosis factor alpha-induced DNA-protein complex in astrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970814-4

7 January 2021

Activation of microglial cells by beta-amyloid protein and interferon-gamma.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970814-4

7 January 2021

Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970814-4

7 January 2021

ATP mediates rapid microglial response to local brain injury in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970814-4

7 January 2021

Down-regulation of the macrophage lineage through interaction with OX2 (CD200)

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970814-4

7 January 2021

Control of glial immune function by neurons

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970814-4

7 January 2021

Inhibition of endotoxin-induced nitric oxide synthase production in microglial cells by the presence of astroglial cells: a role for transforming growth factor beta

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970814-4

7 January 2021

Microglia: a sensor for pathological events in the CNS

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970814-4

7 January 2021

Effect of transforming growth factor-beta1 on microglial MHC-class II expression

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970814-4

7 January 2021

Neuroprotective role of phosphodiesterase inhibitor ibudilast on neuronal cell death induced by activated microglia

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970814-4

7 January 2021

Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970814-4

7 January 2021

A proposed dual role of neuromelanin in the pathogenesis of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970814-4

7 January 2021

Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970814-4

7 January 2021

Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970814-4

7 January 2021

Inflammation and neurodegeneration in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970814-4

7 January 2021

Inflammatory regulators in Parkinson's disease: iNOS, lipocortin-1, and cyclooxygenases-1 and -2.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970814-4

7 January 2021

Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970814-4

7 January 2021

Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970814-4

7 January 2021

Temporal and sequential analysis of microglia in the substantia nigra following medial forebrain bundle axotomy in rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970814-4

7 January 2021

Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970814-4

7 January 2021

Matrix metalloproteinase-3: a novel signaling proteinase from apoptotic neuronal cells that activates microglia.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970814-4

7 January 2021

Visualising microglial activation in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970814-4

7 January 2021

Presynaptic and postsynaptic dopaminergic binding densities in the nigrostriatal and mesocortical systems in early Parkinson's disease: a double-tracer positron emission tomography study.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970814-4

7 January 2021

Microglial activation and dopamine terminal loss in early Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970814-4

7 January 2021

In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970814-4

7 January 2021

Nonsteroidal antiinflammatory drug use and the risk for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970814-4

7 January 2021

A randomized, double-blind, futility clinical trial of creatine and minocycline in early Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970814-4

7 January 2021

Clinical research. Testing a novel strategy against Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970814-4

7 January 2021

10.1016/S1353-8020(09)70814-4

Identifiers

DOI

1 reference

release_eccbz54mufertadbm7k767oelm

21 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/eccbz54mufertadbm7k767oelm

24 November 2022

mapped directly with Wikidata item

1 reference